Explanatory and pragmatic attitudes in therapeutical trials, J Chronic Dis, vol.20, issue.8, pp.637-685, 1967. ,
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies, J Health Econ, vol.18, issue.3, pp.341-64, 1999. ,
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis, Med Decis Making, vol.18, issue.2, pp.68-80, 1998. ,
Applied Statistical Decision theory, 1961. ,
Cost-effectiveness analysis alongside clinical trials II-an ISPOR good research practices task force report, Value Health, vol.18, issue.2, pp.161-72, 2015. ,
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting, Clinical research, vol.342, 1548. ,
Clinical trials: a methodologic perspective, 2005. ,
Clinical Trials: Design, conduct and analysis, 2012. ,
Power and sample size calculations for stochastic costeffectiveness analysis, Med Decis Making, vol.18, issue.2, pp.81-92, 1998. ,
Sample size and power for cost-effectiveness analysis (part 1), PharmacoEconomics, vol.29, issue.3, pp.189-98, 2011. ,
Sample size calculation in economic evaluations, Health Econ, vol.7, issue.4, pp.327-362, 1998. ,
The value of information and optimal clinical trial design, Stat Med, vol.24, issue.12, pp.1791-806, 2005. ,
Incremental net benefit in randomized clinical trials, Stat Med, vol.20, issue.11, pp.1563-74, 2001. ,
Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trial, Eur J Gastroenterol Hepatol, vol.16, issue.6, pp.543-552, 2004. ,
Applied methods of costeffeciveness analysis in health care, 2011. ,
The half-life of truth: what are appropriate time horizons for research decisions?, Med Decis Making, vol.28, issue.3, pp.287-99, 2008. ,
Sample size calculations in clinical research, 2008. ,
, Choix méthodologiques pour l'évaluation économique à la HAS, 2011.
Clinical research for rare disease: opportunities, challenges, and solutions, Mol Genet Metab, vol.96, issue.1, pp.20-26, 2009. ,
How sensitive are cost-effectiveness analyses to choice of parametric distributions?, Med Decis Making, vol.25, issue.4, pp.416-439, 2005. ,
Time and expected value of sample information wait for no patient, Value Health, vol.11, issue.3, pp.522-528, 2008. ,